» Articles » PMID: 17355951

Interplay of Distinct Growth Factors During Epithelial Mesenchymal Transition of Cancer Progenitor Cells and Molecular Targeting As Novel Cancer Therapies

Overview
Journal Ann Oncol
Publisher Elsevier
Specialty Oncology
Date 2007 Mar 16
PMID 17355951
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

In this review, we describe the critical functions assumed by the interplay of epidermal growth factor, hedgehog, Wnt/beta-catenin, tumor growth factor-beta and integrin signaling cascades in tumorigenic and migrating cancer progenitor cells and activated stromal cells during carcinogenesis. These growth factors provide an important role for the sustained growth and survival of tumorigenic cancer progenitor cells and their progeny by up-regulating numerous mitotic and antiapoptotic signaling cascades. Furthermore, these potent morphogens may cooperate for inducing the molecular events associated with the epithelial-mesenchymal program in cancer cells including the alterations in epithelial cell shape and motility through the dissociation of intercellular adherens junctions. Of therapeutic interest, new strategies for the development of more effective clinical treatments against the locally aggressive and invasive cancers based on the molecular targeting of deregulated signaling elements in tumorigenic and migrating cancer cells and their local microenvironment are also described.

Citing Articles

Tumor-derived mesenchymal progenitor cell-related genes in the regulation of breast cancer proliferation.

Chen Y, Zhu L, Wang Y, Hu J, Zhang H, Zhu J Gland Surg. 2024; 13(3):325-339.

PMID: 38601284 PMC: 11002474. DOI: 10.21037/gs-23-387.


Will metformin use lead to a decreased risk of thyroid cancer? A systematic review and meta-analyses.

Li H, Chen Y, Hu L, Yang W, Gao Z, Liu M Eur J Med Res. 2023; 28(1):392.

PMID: 37773165 PMC: 10542235. DOI: 10.1186/s40001-023-01287-0.


Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes.

Dutta S, Shah R, Singhal S, Dutta S, Bansal S, Sinha S Drug Des Devel Ther. 2023; 17:1907-1932.

PMID: 37397787 PMC: 10312383. DOI: 10.2147/DDDT.S409373.


Reprogramming of glucose metabolism via PFKFB4 is critical in FGF16-driven invasion of breast cancer cells.

Kar S, Maji N, Sen K, Roy S, Maity A, Ghosh Dastidar S Biosci Rep. 2023; 43(8).

PMID: 37222403 PMC: 10407156. DOI: 10.1042/BSR20230677.


IRF2 Destabilizes Oncogenic KPNA2 to Modulate the Development of Osteosarcoma.

Xia S, Ma Y J Oncol. 2022; 2022:9973519.

PMID: 36199790 PMC: 9529396. DOI: 10.1155/2022/9973519.